Siguazodan
Siguazodan
 |
| Names |
| IUPAC name
1-Cyano-2-methyl-3-[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]guanidine |
| Identifiers |
| ChemSpider |
65101 |
InChI=1S/C14H16N6O/c1-9-7-12(21)19-20-13(9)10-3-5-11(6-4-10)18-14(16-2)17-8-15/h3-6,9H,7H2,1-2H3,(H,19,21)(H2,16,17,18)
Key: NUHPODZZKHQQET-UHFFFAOYSA-N
|
| Jmol-3D images |
Image |
| PubChem |
72124 |
CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N
|
| Properties |
| Molecular formula |
C14H16N6O |
| Molar mass |
284.32 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) |
|
| Infobox references |
|
|
Siguazodan is a phosphodiesterase inhibitor.[1]
References
- ↑ Sosroseno, W; Sugiatno, E (2008). "Cyclic-AMP-dependent proliferation of a human osteoblast cell line (HOS cells) induced by hydroxyapatite: Effect of exogenous nitric oxide". Acta bio-medica : Atenei Parmensis 79 (2): 110–6. PMID 18788505.